- Home
- GHI vs PRE Comparison
GHI vs PRE Comparison
Compare GHI & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GHI
Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Current Price
Company Overview
Basic Information| Metric | GHI | PRE |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.5M | 131.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GHI | PRE |
|---|---|---|
| Price | $8.11 | $18.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $13.00 | ★ $32.00 |
| AVG Volume (30 Days) | 168.8K | ★ 183.3K |
| Earning Date | 02-19-2026 | 11-10-2025 |
| Dividend Yield | ★ 19.27% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | $26,247,399.00 | ★ $77,079,000.00 |
| Revenue This Year | $201.02 | $219.28 |
| Revenue Next Year | $2.87 | $124.38 |
| P/E Ratio | $45.52 | ★ N/A |
| Revenue Growth | N/A | ★ 201.54 |
| 52 Week Low | $6.01 | $3.10 |
| 52 Week High | $13.29 | $18.48 |
Technical Indicators
Market Signals| Indicator | GHI | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 62.47 | 67.15 |
| Support Level | $7.63 | $15.14 |
| Resistance Level | $8.06 | $16.33 |
| Average True Range (ATR) | 0.34 | 1.15 |
| MACD | 0.06 | 0.09 |
| Stochastic Oscillator | 97.25 | 95.80 |
Price Performance
Historical ComparisonAbout GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.